Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
McKinsey
Baxter
Cipla
Fish and Richardson

Generated: September 18, 2019

DrugPatentWatch Database Preview

Litigation Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2013)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2013)

Docket   Try a Free Trial Date Filed 2013-08-22
Court District Court, D. Delaware Date Terminated 2014-09-17
Cause 35:271 Patent Infringement Assigned To Richard Gibson Andrews
Jury Demand None Referred To
Parties LTS LOHMANN THERAPIE-SYSTEME AG; NOVARTIS AG; NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.; NOVARTIS PHARMA AG; NOVARTIS PHARMACEUTICALS CORPORATION; PAR PHARMACEUTICAL INC.
Patents 4,948,807; 5,344,656; 5,462,745; 5,602,176; 6,316,023; 6,335,031
Attorneys Daniel M. Silver; Katharine Crawford Lester; Katharine Lester Mowery; Michael P. Kelly; Steven J. Fineman
Link to Docket External link to docket
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc.
The small molecule drugs covered by the patents cited in this case are   Try a Free Trial and   Try a Free Trial .

Details for Novartis Pharmaceuticals Corporation v. Par Pharmaceutical Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-08-22 1 Exhibit A REFERENCES, should read: -- 4,948,807 8/1990 Rosin et al. ........…States Patent (10) Patent N0.: …UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. : 6,335,031…error appears in the above-identi?ed patent and that said Letters Patent is hereby corrected as shown…UNITED STATES PATENT AND TRADEMARK OFFICE CERTIFICATE OF CORRECTION PATENT NO. : 6,335,031 External link to document
2013-11-18 16 United States Letters Patent No. 6,335,031 (“the ‘031 patent”). The ‘031 patent was duly and legally issued… 9606290v.l BACKGROUND 9. U.S. Patent l\lo. 6,335,031 (“’031 patent”) entitled “TTS containing an antioxidant…Act, 28 U.S.C. § 2201 el seq., that U.S. Patent No. 6,335,031 is invalid and not infringed by Par. JURISDICTION…Declaratory .]udgment regarding invalidity of U.S. Patent No. 6,335,031) 13. Par realleges paragraphs 1-12 of the…Judgment regarding non-infringement of U.S. Patent No. 6,335,031) 16. Par realleges paragraphs 1-12 of the External link to document
2013-08-22 3 Date of Expiration of Patent: 6,335,031 (January 8, 2019 ) … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …Received Notice: 07/12/2013. Date of Expiration of Patent: 01/08/2019.Thirty Month Stay Deadline: 1/12/2016… SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW… 17 September 2014 1:13-cv-01467 830 Patent None District Court, D. Delaware External link to document
2013-08-22 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,335,031;. (dmp, ) (Entered:…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 6,335,031 … G ✔ Patents. ( G the patent action involves 35 U.S.C. § 292.): …Therapie-Systeme AG PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT External link to document
2014-06-18 72 Q. And this is United States Patent Number 4 6,316,023; is that right? 5 A. That… the '031 patent. As Your Honor is aware, the 8 claims of the '031 patent fall into two… the '031 2 patent, the exemplary antioxidant in the '031 3 patent includes antioxidants…031 23 patent. But Your Honor will hear from 24 Dr. Klibanov that the '031 patent provides …mean that the patent is not 22 enabled. 23 As a matter of law, the patent need 24 External link to document
2014-09-17 87 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,335,031. (Attachments: # 1 … 17 September 2014 1:13-cv-01467 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Merck
QuintilesIMS
Cantor Fitzgerald
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.